GALECTIN-3 IS A THERAPEUTIC TARGET FOR CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Fukumori, Tomoharu
Dondoo, Tsogt-Ochir
Daizumoto, Kei
Fukawa, Tomoya
Yamamoto, Yasuyo
Yamaguchi, Kunihisa
Takahashi, Masayuki
Kanayama, Hiro-omi
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.2049
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP55-06
引用
收藏
页码：E675 / E675
页数：1
相关论文
共 50 条
  • [31] Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer
    Kishore, Chandra
    Zi, Xiaolin
    [J]. CURRENT PHARMACOLOGY REPORTS, 2023, 9 (05) : 261 - 274
  • [32] Aberrant HER2 signaling is a therapeutic target in a subset of castration-resistant prostate cancer
    Russo, Joshua W.
    Gao, Xin
    Einstein, David J.
    Bubley, Glenn J.
    Balk, Steven P.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [33] Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer
    Ripoll, Giselle V.
    Pifano, Marina
    Garona, Juan
    Alonso, Daniel F.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 9
  • [34] TP53INP1 as new therapeutic target in castration-resistant prostate cancer
    Giusiano, Sophie
    Baylot, Virginie
    Andrieu, Claudia
    Fazli, Ladan
    Gleave, Martin
    Iovanna, Juan Lucio
    Taranger-Charpin, Colette
    Garcia, Stephane
    Rocchi, Palma
    [J]. PROSTATE, 2012, 72 (12): : 1286 - 1294
  • [35] Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target
    Shiota, Masaki
    Yokomizo, Akira
    Naito, Seiji
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2011, 47 (01) : R25 - R41
  • [36] 3β-Hydroxysteroid Dehydrogenase Is a Possible Pharmacological Target in the Treatment of Castration-Resistant Prostate Cancer
    Evaul, Kristen
    Li, Rui
    Papari-Zareei, Mahboubeh
    Auchus, Richard J.
    Sharifi, Nima
    [J]. ENDOCRINOLOGY, 2010, 151 (08) : 3514 - 3520
  • [37] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
  • [38] Diethylstilbestrol in castration-resistant prostate cancer
    Wilkins, Anna
    Shahidi, Mehdi
    Parker, Chris
    Gunapala, Ranga
    Thomas, Karen
    Huddart, Robert
    Horwich, Alan
    Dearnaley, David
    [J]. BJU INTERNATIONAL, 2012, 110 (11B) : E727 - E735
  • [39] Abiraterone and castration-resistant prostate cancer
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2013, 14 (02): : E48 - E48
  • [40] Strategies in castration-resistant prostate cancer
    Bessede, Th
    [J]. PROGRES EN UROLOGIE, 2011, 21 : S68 - S71
12345